The annual fee that you pay to the fund company for managing your investment. The lower the expense ratio, the better. This is not an investment recommendation.

Dividends

1.35%Dividend Yield

Jan 26

$0.59

Jul 25

$0.03

Jan 22

$0.03

Jan 21

$0.13

10Y Growth

N/A

5Y Growth

88.8%

3Y Growth

N/A

1Y Growth

N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GNOM. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

ARK Genomic Revolution

ARKG

Mkt Cap0

ARK Genomic Revolution ETF focuses on companies likely to benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments, genomics, and molecular diagnostics, making it a direct competitor in the genomics investment space.

iShares Genomics Immunology and Healthcare

IDNA

Mkt Cap0

iShares Genomics Immunology and Healthcare ETF aims to track an index composed of developed and emerging market companies that could gain from long-term growth and innovation in genomics, immunology, and bioengineering, closely aligning with GNOM's focus on biotechnology and genomics.

Principal Healthcare Innovators

BTEC

Mkt Cap0

Principal Healthcare Innovators Index ETF focuses on companies that are leading the charge in healthcare innovation, including genomics and biotechnology, making it a competitor by investing in a similar space as GNOM.

VanEck Biotech

BBH

Mkt Cap0

VanEck Vectors Biotech ETF invests in companies involved in the development, production, and marketing of pharmaceuticals, including genomics and biotechnology, positioning it as a competitor to GNOM by targeting a similar sector.

First Trust NYSE Arca Biotechnology Index Fund

FBT

Mkt Cap0

First Trust NYSE Arca Biotechnology Index Fund is focused on companies engaged in the research, development, manufacturing, and distribution of various biotechnological products, therapies, and services, including genomics, making it a competitor.

iShares Biotechnology

IBB

Mkt Cap0

iShares Biotechnology ETF offers exposure to U.S. biotechnology and pharmaceutical companies, which includes firms involved in genomics and genetic analysis, making it a competitor to GNOM in the biotech investment space.

State Street SPDR S&P Biotech

XBI

Mkt Cap0

SPDR S&P Biotech ETF provides exposure to the biotech sector of the S&P, which includes companies involved in the innovation and development of new treatments and technologies in genomics, competing with GNOM's investment focus.

Invesco Biotechnology & Genome

PBE

Mkt Cap0

Invesco Dynamic Biotechnology & Genome ETF is focused on companies that are principally engaged in the research, development, manufacturing, and marketing of products based on genetic analysis and genetic engineering, making it a direct competitor to GNOM.

ALPS Medical Breakthroughs

SBIO

Mkt Cap0

ALPS Medical Breakthroughs ETF invests in the healthcare sector, including small- and mid-cap biotechnology and pharmaceutical companies that have one or more drugs in Phase II or Phase III FDA clinical trials, indirectly competing with GNOM by focusing on innovative healthcare solutions.

Holdings

Regions

Sectors

About

The Global X Genomics & Biotechnology ETF (GNOM) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index.

CEO

Country

United States

ISIN

US37960A2143

Listings

0 Comments

Share your thoughts

FAQ

What is Global X Genomics & Biotechnology stock price today?▼

The current price of GNOM is $47.27 USD — it has increased by +2.29% in the past 24 hours. Watch Global X Genomics & Biotechnology stock price performance more closely on the chart.

What is Global X Genomics & Biotechnology stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Global X Genomics & Biotechnology stocks are traded under the ticker GNOM.

Is Global X Genomics & Biotechnology stock price growing?▼

GNOM stock has risen by +7.85% compared to the previous week, the month change is a +7.68% rise, over the last year Global X Genomics & Biotechnology has showed a +56.36% increase.

Does Global X Genomics & Biotechnology pay dividends?▼

Yes, GNOM dividends are paid semi-annual. The last dividend per share was 0.59 USD. As of today, Dividend Yield (FWD)% is 1.35%.

In which sector is Global X Genomics & Biotechnology located?▼

Global X Genomics & Biotechnology operates in the Other sector.

When did Global X Genomics & Biotechnology complete a stock split?▼

The last stock split for Global X Genomics & Biotechnology was on September 02, 2025 with a ratio of 1:4.